Analysen von Emily Field

10.08.23 Novo Nordisk Overweight Barclays Capital
08.08.23 Novo Nordisk Overweight Barclays Capital
08.08.23 Bayer Overweight Barclays Capital
08.08.23 Merck Overweight Barclays Capital
07.08.23 Merck Overweight Barclays Capital
25.07.23 Bayer Overweight Barclays Capital
24.07.23 Bayer Overweight Barclays Capital
24.07.23 Merck Overweight Barclays Capital
21.06.23 Bayer Overweight Barclays Capital
06.06.23 Merck Overweight Barclays Capital
05.06.23 AstraZeneca Overweight Barclays Capital
25.05.23 Bayer Overweight Barclays Capital
23.05.23 Novo Nordisk Overweight Barclays Capital
23.05.23 Sanofi Overweight Barclays Capital
15.05.23 Merck Overweight Barclays Capital
12.05.23 Bayer Overweight Barclays Capital
11.05.23 Merck Overweight Barclays Capital
02.05.23 Merck Overweight Barclays Capital
25.04.23 Bayer Overweight Barclays Capital
20.04.23 Novo Nordisk Overweight Barclays Capital
14.04.23 Novo Nordisk Overweight Barclays Capital
13.04.23 Merck Overweight Barclays Capital
12.04.23 AstraZeneca Overweight Barclays Capital
12.04.23 Novo Nordisk Overweight Barclays Capital
27.03.23 Sanofi Overweight Barclays Capital
28.02.23 Bayer Overweight Barclays Capital
09.02.23 Bayer Overweight Barclays Capital
25.01.23 AstraZeneca Overweight Barclays Capital
25.01.23 Roche Overweight Barclays Capital
25.01.23 Bayer Overweight Barclays Capital
25.01.23 Merck Overweight Barclays Capital
25.01.23 Novo Nordisk Overweight Barclays Capital
11.01.23 Bayer Overweight Barclays Capital
10.01.23 Bayer Overweight Barclays Capital
09.01.23 Novo Nordisk Overweight Barclays Capital
09.01.23 AstraZeneca Overweight Barclays Capital
23.12.22 AstraZeneca Overweight Barclays Capital
23.12.22 Novo Nordisk Overweight Barclays Capital
23.12.22 Merck Overweight Barclays Capital
23.12.22 Roche Overweight Barclays Capital
23.12.22 Bayer Overweight Barclays Capital
22.11.22 Merck Overweight Barclays Capital
18.11.22 Bayer Overweight Barclays Capital
15.11.22 Merck Overweight Barclays Capital
14.11.22 AstraZeneca Overweight Barclays Capital
14.11.22 Novo Nordisk Overweight Barclays Capital
14.11.22 Roche Overweight Barclays Capital
10.11.22 Merck Overweight Barclays Capital
08.11.22 Bayer Overweight Barclays Capital
02.11.22 Bayer Overweight Barclays Capital